Search Results - "BRINK, Ingo"

Refine Results
  1. 1
  2. 2
  3. 3

    Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity by Yamada, Kiyoshi, Brink, Ingo, Bissé, Emmanuel, Epting, Thomas, Engelhardt, Rupert

    Published in Journal of dermatology (01-05-2005)
    “…Using human (SK‐MEL 23, SK‐MEL 24 and G361) and murine (B16) melanoma cell lines, the coregulatory potential of the uptake of the positron emission tomography…”
    Get full text
    Journal Article
  4. 4

    FDG-PET imaging for the staging and follow-up of small cell lung cancer by Schumacher, T, Brink, I, Mix, M, Reinhardt, M, Herget, G, Digel, W, Henke, M, Moser, E, Nitzsche, E

    Published in European Journal of Nuclear Medicine (01-04-2001)
    “…The staging procedures for small cell lung cancer do not differ appreciably from those for other forms of lung cancer. For practical purposes, the TNM stages…”
    Get full text
    Journal Article
  5. 5

    Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome by REINHARDT, Michael J, BRINK, Ingo, JOE, Alexius Y, VON MALLEK, Dirk, EZZIDDIN, Samer, PALMEDO, Holger, KRAUSE, Thomas M

    “…This study was performed with three aims. The first was to analyse the effectiveness of radioiodine therapy in Graves' disease patients with and without…”
    Get full text
    Journal Article
  6. 6

    Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Accumulation in Melanoma Cells: Is FDG a Substrate of Multidrug Resistance (MDR)? by Yamada, Kiyoshi, Brink, Ingo, Engelhardt, Rupert

    Published in Journal of dermatology (01-05-2005)
    “…In order to specify the influence of multidrug‐resistance (MDR) on the accumulation of the PET tracer, F‐18 FDG ([Fluorine‐18] 2‐fluoro‐2‐deoxy‐d‐glucose, in…”
    Get full text
    Journal Article
  7. 7

    Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis by NITZSCHE, Egbert U, HOEGERLE, Stefan, MIX, Michael, BRINK, Ingo, OTTE, Andreas, MOSER, Ernst, IMDAHL, Andreas

    Published in European journal of nuclear medicine (01-02-2002)
    “…The diagnostic utility of fluorine-18 2-deoxy-D-glucose positron emission tomography (FDG PET) for the non-invasive differentiation of focal pancreatic lesions…”
    Get full text
    Journal Article
  8. 8

    First clinical evidence that imaging with somatostatin receptor antagonists is feasible by Wild, Damian, Fani, Melpomeni, Behe, Martin, Brink, Ingo, Rivier, Jean E F, Reubi, Jean Claude, Maecke, Helmut R, Weber, Wolfgang A

    Published in Journal of Nuclear Medicine (01-09-2011)
    “…Preclinical studies have indicated that somatostatin receptor (sst)-expressing tumors demonstrate higher uptake of radiolabeled sst antagonists than of sst…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly 18 FDG-PET-positive masses by Maschmeyer, Georg, Brink, Ingo, Jähne, Doris, Arnold, Renate, Schega, Olaf

    Published in European journal of haematology (01-09-2017)
    “…We report on a multidisciplinary management of a 68-year-old AML patient presenting with a PET-positive mediastinal tumour typical for lymph node metastasis…”
    Get full text
    Journal Article
  11. 11

    Reproducibility of PET brain mapping of cancer patients by Tashiro, Manabu, Juengling, Freimut D., Reinhardt, Michael J., Brink, Ingo, Hoegerle, Stefan, Mix, Michael, Kubota, Kazuo, Yamaguchi, Keiichiro, Itoh, Masatoshi, Sasaki, Hidetada, Moser, Ernst, Nitzsche, Egbert U.

    Published in Psycho-oncology (Chichester, England) (01-03-2000)
    “…Twenty German cancer patients (56.9±12.7 years old) without brain metastasis underwent neurological PET. The acquired brain data were compared to the data of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly 18FDG‐PET‐positive masses by Maschmeyer, Georg, Brink, Ingo, Jähne, Doris, Arnold, Renate, Schega, Olaf

    Published in European journal of haematology (01-09-2017)
    “…We report on a multidisciplinary management of a 68‐year‐old AML patient presenting with a PET‐positive mediastinal tumour typical for lymph node metastasis…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Thymic Carcinoma with Overexpression of Mutated KIT and the Response to Imatinib by Mikesch, Kristina, Marx, Alexander, Dirnhofer, Stefan, Ströbel, Philipp, Jakob, Andreas, Hartmann, Martina, Brink, Ingo

    Published in The New England journal of medicine (17-06-2004)
    “…To the Editor: In April 2002, a 54-year-old man presented with thoracic pain and respiratory distress; a mediastinal mass, 7.7 by 6 cm, was found on…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Comparison of C-11 Methionine and C-11 Choline for PET Imaging of Brain Metastases: A Prospective Pilot Study by Rottenburger, Christof, Hentschel, Michael, Kelly, Thomas, Trippel, Michael, Brink, Ingo, Reithmeier, Thomas, Tobias Meyer, Philipp, Nikkhah, Guido

    Published in Clinical nuclear medicine (01-08-2011)
    “…PURPOSE:The aim of the study was the comparison of C-11 methionine (MET) and C-11 choline (CHO) in the positron emission tomography (PET) imaging of brain…”
    Get full text
    Journal Article